These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22413537)

  • 41. Endotoxin removal by polymyxin B immobilized cartridge inactivates circulating proapoptotic factors.
    Martin EL; Ranieri VM
    Contrib Nephrol; 2010; 167():65-76. PubMed ID: 20519900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized controlled trial.
    Klein DJ; Foster D; Schorr CA; Kazempour K; Walker PM; Dellinger RP
    Trials; 2014 Jun; 15():218. PubMed ID: 24916483
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extracorporeal removal of endotoxin: the polymyxin B-immobilized fiber cartridge.
    Tani T; Shoji H; Guadagni G; Perego A
    Contrib Nephrol; 2010; 167():35-44. PubMed ID: 20519897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in plasma interleukin-18 by direct hemoperfusion with polymyxin B-immobilized fiber in patients with septic shock.
    Nakamura T; Kawagoe Y; Suzuki T; Shoji H; Ueda Y; Kobayashi N; Koide H
    Blood Purif; 2005; 23(6):417-20. PubMed ID: 16141713
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Direct hemoperfusion using polymyxin-B immobilized fiber for severe septic patients with hematological disorders: a single-center analysis.
    Mori M; Onaka T; Yonezawa A; Kitagawa T; Sasaki Y; Imada K
    J Infect Chemother; 2014 Apr; 20(4):282-4. PubMed ID: 24485325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selection of hemoperfusion therapy for patients with septic shock on the basis of the primary disease.
    Kanno Y; Nemoto H; Nakamoto H; Okada H; Sugahara S; Nishidome K; Yamashita Y; Suzuki H
    J Artif Organs; 2003; 6(3):205-10. PubMed ID: 14598105
    [TBL] [Abstract][Full Text] [Related]  

  • 47. VASOPRESSOR REDUCTION EFFECT OF POLYMYXIN B HEMOPERFUSION IN PATIENTS WITH PERITONITIS-INDUCED SEPTIC SHOCK: A PROPENSITY SCORE-MATCHED ANALYSIS.
    Cho A; Oh SY; Lee H; Ryu HG
    Shock; 2024 Jul; 62(1):69-73. PubMed ID: 38661146
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review.
    Cruz DN; Perazella MA; Bellomo R; de Cal M; Polanco N; Corradi V; Lentini P; Nalesso F; Ueno T; Ranieri VM; Ronco C
    Crit Care; 2007; 11(2):R47. PubMed ID: 17448226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.
    Cruz DN; Antonelli M; Fumagalli R; Foltran F; Brienza N; Donati A; Malcangi V; Petrini F; Volta G; Bobbio Pallavicini FM; Rottoli F; Giunta F; Ronco C
    JAMA; 2009 Jun; 301(23):2445-52. PubMed ID: 19531784
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A longer duration of polymyxin B-immobilized fiber column hemoperfusion improves pulmonary oxygenation in patients with septic shock.
    Mitaka C; Tsuchida N; Kawada K; Nakajima Y; Imai T; Sasaki S
    Shock; 2009 Nov; 32(5):478-83. PubMed ID: 19295483
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polymyxin B for endotoxin removal in sepsis.
    Cavaillon JM
    Lancet Infect Dis; 2011 Jun; 11(6):426-7. PubMed ID: 21616454
    [No Abstract]   [Full Text] [Related]  

  • 52. The effect of continuous veno-venous hemofiltration or direct hemoperfusion with polymyxin B-immobilized fiber on neutrophil respiratory oxidative burst in patients with sepsis and septic shock.
    Naka T; Shinozaki M; Akizawa T; Shima Y; Takaesu H; Nasu H
    Ther Apher Dial; 2006 Feb; 10(1):7-11. PubMed ID: 16556130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of polymyxin B hemoperfusion on the outcome of patients with sepsis and septic shock.
    Lin WT; Lai CC; Wang JJ; Chao CM
    J Infect; 2020 Mar; 80(3):350-371. PubMed ID: 31770534
    [No Abstract]   [Full Text] [Related]  

  • 54. Direct hemoperfusion with a polymyxin B column versus vasopressin for gram negative septic shock: a matched cohort study of the effect on survival.
    Sawa N; Ubara Y; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hoshino J; Suwabe T; Uchida N; Wake A; Taniguchi S; Takaichi K
    Clin Nephrol; 2013 Jun; 79(6):463-70. PubMed ID: 23253903
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polymyxin B hemoperfusion in septic shock: just look at the evidence!
    Antonelli M; Cutuli SL; Ronco C
    Intensive Care Med; 2015 Sep; 41(9):1731-2. PubMed ID: 26197847
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of endotoxin absorber hemoperfusion on microcirculation in septic pigs.
    Yeh YC; Yu LC; Wu CY; Cheng YJ; Lee CT; Sun WZ; Tsai JC; Lin TY;
    J Surg Res; 2017 May; 211():242-250. PubMed ID: 28501124
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of prothrombin time-International Normalized Ratio on outcome of patients with septic shock receiving polymyxin B cartridge hemoperfusion.
    Ishizuka M; Tago K; Kubota K
    Surgery; 2014 Jul; 156(1):168-75. PubMed ID: 24929766
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polymyxin B hemoperfusion in sepsis: growing body of evidence and occasional conflicting results.
    Antonelli M; Ronco C
    Blood Purif; 2015; 39(1-3):I-II. PubMed ID: 25998615
    [No Abstract]   [Full Text] [Related]  

  • 59. Anandamide absorption by direct hemoperfusion with polymixin B-immobilized fiber improves the prognosis and organ failure assessment score in patients with sepsis.
    Kohro S; Imaizumi H; Yamakage M; Masuda Y; Namiki A; Asai Y; Maruyama I
    J Anesth; 2006; 20(1):11-6. PubMed ID: 16421670
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeted therapy using polymyxin B hemadsorption in patients with sepsis: a post-hoc analysis of the JSEPTIC-DIC study and the EUPHRATES trial.
    Osawa I; Goto T; Kudo D; Hayakawa M; Yamakawa K; Kushimoto S; Foster DM; Kellum JA; Doi K
    Crit Care; 2023 Jun; 27(1):245. PubMed ID: 37344804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.